Accordingly, pharmacological inhibitors or specific antisense oligonucleotides inhibiting STAT6 have shown interesting properties in vitro as well as in animal models to limit liver fibrosis or HCC occurrence/progression. The gene discussed is STAT6; the disease is Hepatic fibrosis.